|
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
|
Mifepristone and misoprostol
|
Methotrexate and misoprostol
|
Misoprostol alone
|
|
Day 2-4 (Home): Misoprostol is self-administered vaginally or buccally at home. Nearly 2/3 of women will have a complete abortion within four hours of the misoprostol administration; 90% of women will have a complete abortion within 24 hours of misoprostol administration. Day 7-14 (Clinic): The woman returns to the clinic for follow-up and a clinician assesses for the completion of the abortion. If the abortion is incomplete (2%-5% of cases), the clinician will discuss treatment options with the patients. These options include waiting and re-evaluating, administering additional misoprostol, or performing an aspiration abortion. Increasingly, women are given the option of returning to clinic for follow-up only if they experience severe side effects, suspect an ongoing pregnancy or incomplete abortion, or have evidence of other complications. Thus a follow-up clinic visit may be recommended but not required. |
Day 3-7 (Home): Misoprostol is self-administered vaginally at home. Day 8 (Clinic): A clinician performs
a vaginal ultrasound to determine if the abortion is complete.
Day 15 (Clinic, if necessary): The patient is assessed for continued pregnancy. If cardiac activity is detected, a surgical termination is performed. If no cardiac activity is detected, the woman is asked to return in three weeks. Day 28-45 (Clinic, if necessary): The patient is assessed for continued pregnancy. If the abortion is incomplete (5% of cases), an aspiration termination is performed. |
|
|
Please contact us with suggestions, updates, or link requests at medicationabortion@ibisreproductivehealth.org Your access and use of this website is subject to certain terms of use. By viewing web pages in this site, you accept, without limitation or qualification, these terms. Read our privacy statement. Last updated: September 2009 |